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MALIGNANT TRANSFORMATION of cells
may be accompanied by a change in
responsiveness to hormonal stimulation.
Since hormones exert their effects on cells
by binding to specific receptors, the re-
sponsiveness of normal or neoplastic
tissue to hormonal stimulation is at least
partly determined by the presence and
concentration of hormone receptors. A
number of experimental tumours possess
cell-membrane receptors for insulin
(Capeau et al., 1978; Harmon & Hilf,
1976; Heuson et al., 1972; Pezzino et al.,
1979) and the growth of some of these
tumours is affected by changes in the
ambient insulin concentration (Cohen &
Hilf, 1975; Heuson et al., 1972). Among
human tumours, only breast cancer has
been shown to possess insulin receptors
(Holdaway & Friesen, 1977; Osborne et
al., 1978). A variety of cancers have here
been studied by us in order to test the
hypothesis that most, if not all, human
cancers contain specific receptors for
insulin.
Sixty-seven tissue samples were ob-
tained, including 40 tumours (23 breast
carcinomas, 12 colon carcinomas, 2
phaeochromocytomas, a gastric adeno-
carcinoma, an adrenal carcinoma and a
lymphoma), 24 specimens of normal fat
and 3 of muscle. All samples were col-
lected at surgery and transported to the
Pathology Department on ice. Specimens
were carefully dissected free of non-
tumour tissue, and in any case of doubt a
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small tissue sample was sent for inde-
pendent histological examination to en-
sure that only tumour tissue was pro-
cessed. Samples were stored at -700C
within 2 h ofsurgical removal and assayed
within 2 weeks of collection. Partially
purified plasma membranes were pre-
pared, using a modification (Holdaway &
Friesen, 1977) of the method of Shiu &
Friesen (Shiu et al., 1973). In brief, tissue
was homogenized in cold 0-3M sucrose
with a polytron homogenizer and centri-
fuged at 15,000 g for 20 min at 4°C. The
supernatant was centrifuged at 100,000 g
for 60 min and the resulting pellet was
resuspended in a volume of assay buffer
(0-025M tris HCI, 10mM MgCl2, pH 7-6,
0-1% bovine serum albumin) estimated to
give a final protein concentration of
3 mg/ml. This pellet is enriched in 5'-
nucleotidase (Shiu & Friesen, 1974) and
contains receptors for both prolactin and
insulin (Holdaway & Friesen, 1977). Pro-
tein concentration was measured by the
Lowry method.
The insulin-binding assay was per-
formed using porcine insulin (24 u/mg)
kindly -provided by Novo Industries
(Copenhagen) and insulin was labelled
with 1251 using chloramine-T (Freychet et
al., 1971). Membrane preparations (0-1 ml
containing - 0-3 mg protein) were incu-
bated in duplicate with 1251-labelled
insulin (0.2 ng) and increasing amounts of
unlabelled insulin (0.5-5000 ng) in a total
volume made up to 0-5 ml with assay
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buffer. Samples were incubated at 4°C for
24 h. After incubation the tubes were
centrifuged at 3000 g for 40 min and the
supernatant decanted. The pellet, con-
taining membrane-bound labelled insulin,
was counted for radioacitvity. Specific
binding at each concentration of un-
labelled insulin was calculated as the per-
centage of added counts bound (total
binding) minus the percentage of added
counts bound in the presence of 5000 ng
unlabelled insulin. Such nonspecific bind-
ing, expressed as a percentage of total
counts added, was 5-8%. Scatchard
analysis was used to determine binding-
site concentration and affinity using a
linear least-squares fit to the data. The
range ofinsulin concentrations chosen was
such that the Scatchard analysis could be
performed over the approximate linear
initial portion of the plot, hence the mean
correlation coefficient for all samples was
0 939 (range= 0 715-190). Considering the
range of specific binding seen in the
absence of membranes (0-0.3%0) and in
the presence of placental membranes
denatured by boiling for 30 min (0-1 5%)
a specific binding > 2% was considered
experimentally significant. All specific
binding values were adjusted to a mem-
brane-protein concentration of 3 0 mg/ml,
as specific binding was found to be a linear
function ofprotein concentration over the
range 0 5-5 mg/ml in several tumours and
normal tissues.
Using these methods, significant insulin
binding was detected in all tumour speci-
mens except one breast-tumour sample
which had a particularly low yield of
membrane protein (1.5 mg/ml). In this
specimen, specific binding was 1 8%.
Scatchard analysis of binding of 1251I
insulin to different types of tumour is
shown in Fig. 1, and compared with in-
sulin binding to normal placenta, fat and
muscle. In 2 instances sufficient normal
colon adjacent to a colon carcinoma was
available for analysis of insulin binding.
Comparison of binding to tumour and
normal adjacent tissue is shown in Fig. 2.
The binding characteristics of 1251-insulin
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FIG. 1. Scatchard plots of l251-insuli
biiding to tumours (above) and normal
tissues (below).
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FIG. 2. Scatchard plots of 1251-insulin
binding to colon cancer (0) and adjacent
normal colon (x). All binding per 300 ,g
membrane protein.
were very similar in the normal and neo-
plastic tissue in both cases.
Since insulin degradation by mem-
branes may alter apparent binding (Kahn
et al., 1974) degradation of 1251-insulin by
membranes from normal and tumour
tissue was compared in one specimen of
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colon carcinoma. After incubation of 1251-
insulin with tumour membranes, the
supernatant was reincubated with a fresh
sample of placental membranes and com-
pared with the binding using fresh labelled
hormone. There was little difference in the
rate of insulin degradation between the
2 tissues (14% per 24 h by the tumour
membrane vs 10% per 24 h by the normal-
tissue membranes). This difference was
not sufficient to alter the close similarity
of the Scatchard plots for the binding of
labelled insulin to tumour and normal
colon (Fig. 2). The rate of degradation of
labelled insulin also appeared similar in
3 different types of tumour (colon,
stomach, and breast).
Thus in this investigation we have found
insulin-binding sites in membrane frac-
tions prepared from a variety of different
tumour types, including infiltrating ductal
and colloid carcinoma of the breast,
colonic adenocarcinoma, gastric carcin-
oma, adrenocortical carcinoma, lymph-
oma and phaeochromocytoma. Compari-
son of insulin binding in these tumours
with normal insulin-responsive tissues
reveals marked similarity in binding-site
concentration and affinity (Table).
TABLE.-Characteristics ofbinding of 1251-
insulin to human tissues
Tissue
Tumours
Breast
Colon
Phaeochromo-
cytoma
Adrenal
Stomach
Lymphoma
Normal tissues
Placenta
Fat
Muscle
Binding-site
concentration
(mean fmol/ Binding
0 3 mg affinity
protein (mean
+s.e.) M X 109+s.e.) n
33-1 +6-6 1-38+0-21 23
19-0+ 1-9 1-95+0 30 12
30-0+6-0 1-35+0-10 2
55 1-38 1
32 0-64 1
25 1 10 1
278.1 +32-2 1.08 + 0 09 3
57-4+ 5-7 1-12+0-15 24
39-0+ 10-7 1-15+0-05 3
Scatchard plots were curvilinear both in
tumours and normal tissues (Fig. 1),
indicating decreased affinity of binding
with increasing receptor occupancy. This
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effect appears to be common to insulin
receptors in all normal insulin-responsive
tissues, and has variously been ascribed to
a single class of binding sites with site-to-
site interactions (negative cooperativity)
or to the presence of multiple classes of
binding sites with decreasing affinity but
increasing capacity (Rodbard, 1979). The
similar characteristics of insulin binding
to normal and tumour tissue (Figs 1 & 2)
suggest similar mechanisms operating to
influence binding in neoplastic and non-
neoplastic tissue. Although the specificity
ofthe binding sites for insulin could not be
tested in each tumour type because of the
limited amount of tissue available, the
specificity ofthese binding sites for insulin
has previously been established in breast-
cancer membranes (Holdaway & Friesen,
1977).
Insulin binding to colon carcinoma has
characteristics remarkably similar to
those in adjacent normal colon (Fig. 2).
Previous autoradiographic studies have
shown that insulin binding in tumour
tissue is not simply due to binding to
normal tissue included in the tumour
mass, and in the present study particular
care was taken to exclude normal tissue
from tumour samples. It thus appears
that insulin receptors in normal cells are
preserved during malignant transforma-
tion. This hypothesis would be consistent
with observations in the Zajdela hepatoma
(Capeau et al., 1978) and the R3230AC
rodent mammary carcinoma (Harmon &
Hilf, 1976). In these experimental
tumours, insulin receptors are identical
(though in lower concentration) to re-
ceptors in the non-neoplastic host tissues.
It has however also been shown that
tumours may synthesize "ectopic" hor-
mone receptors, such as the TSH receptor
found in an adrenocortical carcinoma
(Hinshaw & Ney, 1974). In addition, there
is evidence that there may be abnormal
regulation of levels of "normal" insulin
receptors in breast cancer (Benson &
Holdaway, submitted for publication).
Thus the synthesis and regulation of
hormone receptors by tumour tissue may
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differ in several respects from non-
neoplastic tissue. Although insulin binding
was measured in the present studies in
only 6 types of cancer, the finding of
physiological concentrations of high-
affinity binding sites for insulin in all but
one tumour suggests that insulin binding
is a common property of human cancer.
Whether these binding sites are active in
translating the biological signal of insulin
remains to be determined. However, as
insulin affects the growth rate of some
experimental tumours (Cohen & Hilf,
1975; Heuson et al., 1972) the frequent
occurrence of insulin-binding sites in
human cancer suggests that insulin may
help maintain or stimulate the growth of
human tumours.
We are grateful to Professor J. Arthur and the
Department of Pathology for their cooperation in
obtaining tissue specimens. This work was supported
by the Medical Research Council of New Zealand.
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